Bourgeon Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Bourgeon Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4,424	Closed	-$566K	–	115
2025 Q1	$566K	Buy	4,424 +206	+5%	+$27.9K	0.12%	74
2024 Q4	$558K	Buy	4,218 +305	+8%	+$42.9K	0.1%	84
2024 Q3	$570K	Buy	3,913 +168	+4%	+$24.3K	0.11%	72
2024 Q2	$514K	Buy	3,745 +69	+2%	+$9.21K	0.1%	78
2024 Q1	$504K	Buy	3,676 +171	+5%	+$23.4K	0.1%	81
2023 Q4	$476K	Buy	+3,505	New	+$428K	0.11%	77
2021 Q4	–	Sell	-320	Closed	-$52K	–	275
2021 Q3	$52K	Hold	320	–	–	0.01%	162
2021 Q2	$52K	Hold	320	–	–	0.01%	164
2021 Q1	$48K	Hold	320	–	–	0.01%	166
2020 Q4	$48K	Hold	320	–	–	0.01%	148
2020 Q3	$43K	Hold	320	–	–	0.01%	153
2020 Q2	$44K	Hold	320	–	–	0.02%	123
2020 Q1	$34K	Sell	320 -33,556	-99%	-$3.86M	0.02%	123
2019 Q4	$4.08M	Sell	33,876 -970	-3%	-$108K	1.93%	26
2019 Q3	$3.47M	Sell	34,846 -689	-2%	-$72.1K	1.88%	24
2019 Q2	$3.88M	Sell	35,535 -795	-2%	-$84.6K	2.25%	18
2019 Q1	$4.06M	Buy	+36,330	New	+$3.98M	2.38%	20

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Bourgeon Capital Management's IBB Position: Q2 2025 in Review

Bourgeon Capital Management sold out of iShares Biotechnology ETF (IBB) in Q2 2025, closing a stake of 4,424 shares — an estimated $566K sold.

Bourgeon Capital Management first reported a position in IBB in Q1 2019 and held it in 17 quarters. The position peaked at $4.08M in Q4 2019. 797 funds tracked by Wall St. Rank hold IBB as of Q2 2025.

Bourgeon Capital Management reported no remaining iShares Biotechnology ETF position as of Q2 2025 after selling out during the quarter.
Bourgeon Capital Management sold 4,424 iShares Biotechnology ETF shares in Q2 2025, an estimated $566K.
Bourgeon Capital Management first reported a position in iShares Biotechnology ETF in Q1 2019 and held it in 17 quarters.
Bourgeon Capital Management's iShares Biotechnology ETF position peaked at $4.08M in Q4 2019.
797 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2025.

Based on Bourgeon Capital Management's 13F filing for Q2 2025, filed 18 Jul 2025.